Log In
BCIQ
Print this Print this
 

GSK3174998

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionHumanized IgG1 mAb agonist of tumor necrosis factor (TNF) receptor superfamily member 4 (TNFRSF4; OX40; CD134)
Molecular Target Tumor necrosis factor (TNF) receptor superfamily member 4 (OX40) (TNFRSF4) (CD134)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/03/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today